MEDPLUS HEALTH SERVICES
Quarterly Results Analysis [Dec2024]
MEDPLUS HEALTH SERVICES Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,561 Cr | ₹1,576 Cr | ₹1,489 Cr | ₹1,490 Cr | ₹1,441 Cr | ₹1,409 Cr | ₹1,284 Cr | ₹1,253 Cr |
Expenses | ₹1,429 Cr | ₹1,452 Cr | ₹1,395 Cr | ₹1,385 Cr | ₹1,350 Cr | ₹1,323 Cr | ₹1,213 Cr | ₹1,171 Cr |
Operating Income | ₹133 Cr | ₹124 Cr | ₹94 Cr | ₹106 Cr | ₹92 Cr | ₹85 Cr | ₹71 Cr | ₹82 Cr |
Other Income | ₹13 Cr | ₹12 Cr | ₹9 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹14 Cr |
Interest | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr | ₹24 Cr | ₹23 Cr | ₹22 Cr |
Depreciation | ₹62 Cr | ₹63 Cr | ₹60 Cr | ₹59 Cr | ₹57 Cr | ₹55 Cr | ₹52 Cr | ₹56 Cr |
Profit Before Tax | ₹57 Cr | ₹48 Cr | ₹18 Cr | ₹32 Cr | ₹20 Cr | ₹16 Cr | ₹5 Cr | ₹17 Cr |
Profit After Tax | ₹46 Cr | ₹39 Cr | ₹14 Cr | ₹34 Cr | ₹14 Cr | ₹15 Cr | ₹4 Cr | ₹27 Cr |
EPS | ₹3.83 | ₹3.24 | ₹1.20 | ₹2.79 | ₹1.15 | ₹1.22 | ₹0.32 | ₹2.23 |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDPLUS HEALTH SERVICES | -1.4% | 1.3% | 8.1% |
SUN PHARMACEUTICAL INDUSTRIES | 2.3% | 11.7% | 5.1% |
DIVIS LABORATORIES | -1.6% | 4% | 58.7% |
CIPLA | 0.8% | 6.2% | -2.9% |
TORRENT PHARMACEUTICALS | 0.7% | 9.8% | 19.8% |
DR REDDYS LABORATORIES | -1% | 2.8% | -8% |
MANKIND PHARMA | -1.4% | 4.5% | 4.7% |
ZYDUS LIFESCIENCES | 1.1% | 3.5% | -10.8% |
LUPIN | 3.7% | 7.3% | 23.8% |
MEDPLUS HEALTH SERVICES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -0.93 % |
Y-o-Y | 8.32 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹1,561 Cr | -0.93 | |
Sep2024 | ₹1,576 Cr | 5.87 | |
Jun2024 | ₹1,489 Cr | -0.11 | |
Mar2024 | ₹1,490 Cr | 3.40 | |
Dec2023 | ₹1,441 Cr | 2.33 | |
Sep2023 | ₹1,409 Cr | 9.68 | |
Jun2023 | ₹1,284 Cr | 2.50 | |
Mar2023 | ₹1,253 Cr | - |
MEDPLUS HEALTH SERVICES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 6.50 % |
Y-o-Y | 44.39 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹133 Cr | 6.50 | |
Sep2024 | ₹124 Cr | 32.72 | |
Jun2024 | ₹94 Cr | -11.43 | |
Mar2024 | ₹106 Cr | 15.35 | |
Dec2023 | ₹92 Cr | 7.86 | |
Sep2023 | ₹85 Cr | 19.27 | |
Jun2023 | ₹71 Cr | -12.60 | |
Mar2023 | ₹82 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 7.47 % |
Y-o-Y | 33.28 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 8.49% | 7.47 | |
Sep2024 | 7.9% | 25.40 | |
Jun2024 | 6.3% | -11.27 | |
Mar2024 | 7.1% | 11.46 | |
Dec2023 | 6.37% | 5.46 | |
Sep2023 | 6.04% | 8.63 | |
Jun2023 | 5.56% | -14.59 | |
Mar2023 | 6.51% | - |
MEDPLUS HEALTH SERVICES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 18.53 % |
Y-o-Y | 234.70 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹46 Cr | 18.53 | |
Sep2024 | ₹39 Cr | 169.79 | |
Jun2024 | ₹14 Cr | -57.26 | |
Mar2024 | ₹34 Cr | 144.88 | |
Dec2023 | ₹14 Cr | -5.77 | |
Sep2023 | ₹15 Cr | 286.29 | |
Jun2023 | ₹4 Cr | -85.82 | |
Mar2023 | ₹27 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 19.51 % |
Y-o-Y | 209.47 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 2.94 % | 19.51 | |
Sep2024 | 2.46 % | 156.25 | |
Jun2024 | 0.96 % | -57.33 | |
Mar2024 | 2.25 % | 136.84 | |
Dec2023 | 0.95 % | -7.77 | |
Sep2023 | 1.03 % | 255.17 | |
Jun2023 | 0.29 % | -86.32 | |
Mar2023 | 2.12 % | - |
MEDPLUS HEALTH SERVICES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 18.21 % |
Y-o-Y | 233.04 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹3.83 | 18.21 | |
Sep2024 | ₹3.24 | 170.00 | |
Jun2024 | ₹1.2 | -56.99 | |
Mar2024 | ₹2.79 | 142.61 | |
Dec2023 | ₹1.15 | -5.74 | |
Sep2023 | ₹1.22 | 281.25 | |
Jun2023 | ₹0.32 | -85.65 | |
Mar2023 | ₹2.23 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD